Cargando…

Outcomes of patients with childhood B-cell precursor acute lymphoblastic leukaemia with late bone marrow relapses: long-term follow-up of the ALLR3 open-label randomised trial

BACKGROUND: The ALLR3 trial investigated outcomes of children with B-cell precursor acute lymphoblastic leukaemia who had late bone marrow relapses. We analysed long-term follow-up outcomes of these patients. METHODS: ALLR3 was an open-label randomised clinical trial that recruited children aged 1–1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parker, Catriona, Krishnan, Shekhar, Hamadeh, Lina, Irving, Julie A E, Kuiper, Roland P, Révész, Tamas, Hoogerbrugge, Peter, Hancock, Jeremy, Sutton, Rosemary, Moorman, Anthony V, Saha, Vaskar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445853/ https://www.ncbi.nlm.nih.gov/pubmed/30826273 http://dx.doi.org/10.1016/S2352-3026(19)30003-1

Ejemplares similares

Outcome of Central Nervous System Relapses In Childhood Acute Lymphoblastic Leukaemia – Prospective Open Cohort Analyses of the ALLR3 Trial
por: Masurekar, Ashish Narayan, et al.
Publicado: (2014)

Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial
por: Parker, Catriona, et al.
Publicado: (2010)

The optimal use of PEG-Asparaginase in relapsed ALL—lessons from the ALLR3 Clinical Trial
por: Masurekar, A, et al.
Publicado: (2014)

Temporal changes in incidence and pattern of central nervous system relapses in children with acute lymphoblastic leukaemia treated on four consecutive Medical Research Council Trials, 1985–2001
por: Krishnan, Shekhar, et al.
Publicado: (2009)

Acute lymphoblastic leukaemia cells produce large extracellular vesicles containing organelles and an active cytoskeleton
por: Johnson, Suzanne M., et al.
Publicado: (2017)

Unsatisfactory quality of E. coli asparaginase biogenerics in India: Implications for clinical outcomes in acute lymphoblastic leukaemia
por: Sidhu, Jasmeet, et al.
Publicado: (2021)

SOX7 promotes the maintenance and proliferation of B cell precursor acute lymphoblastic cells
por: Cuvertino, Sara, et al.
Publicado: (2016)

Examining treatment responses of diagnostic marrow in murine xenografts to predict relapse in children with acute lymphoblastic leukaemia
por: Alruwetei, Abdulmohsen M., et al.
Publicado: (2020)

Upfront Treatment Influences the Composition of Genetic Alterations in Relapsed Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia
por: Yu, Jiangyan, et al.
Publicado: (2020)

Subgrouping by gene expression profiles to improve relapse risk prediction in paediatric B‐precursor acute lymphoblastic leukaemia
por: Huang, Qingsheng, et al.
Publicado: (2021)

A pediatric regimen for adolescents and young adults with Philadelphia chromosome‐negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trial
por: Ribera, Josep‐Maria, et al.
Publicado: (2020)

Marrow relapse on maintenance chemotherapy in childhood acute lymphoblastic leukaemia.
por: Kearney, P. J., et al.
Publicado: (1979)

Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients
por: Scheijen, Blanca, et al.
Publicado: (2017)

Precursor B‐cell acute lymphoblastic leukaemia—a global view
por: Biondi, Andrea, et al.
Publicado: (2021)

Isolated Intraocular Relapse of Pediatric B-cell Precursor Acute Lymphoblastic Leukaemia Following Chimeric Antigen Receptor T-lymphocyte Therapy
por: Veys, Delphine, et al.
Publicado: (2020)

The cost-effectiveness of pegaspargase versus native asparaginase for first-line treatment of acute lymphoblastic leukaemia: a UK-based cost-utility analysis
por: Hu, Xingdi, et al.
Publicado: (2019)

Erythroleukemia Relapsing as Precursor B-cell Lymphoblastic Leukemia
por: Park, Borae G., et al.
Publicado: (2011)

Testicular relapse in acute lymphoblastic leukaemia: studies with an experimental mouse model.
por: Jackson, H., et al.
Publicado: (1984)

Unravelling the Sequential Interplay of Mutational Mechanisms during Clonal Evolution in Relapsed Pediatric Acute Lymphoblastic Leukemia
por: Antić, Željko, et al.
Publicado: (2021)

5T4 oncofoetal antigen is expressed in high risk of relapse childhood pre-B acute lymphoblastic leukemia and is associated with a more invasive and chemotactic phenotype
por: Castro, Fernanda V, et al.
Publicado: (2012)

Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia
por: Zhu, Y-M, et al.
Publicado: (1999)

Bone Marrow Recovery by Morphometry during Induction Chemotherapy for Acute Lymphoblastic Leukemia in Children
por: Nguyen, Tuong-Vi, et al.
Publicado: (2015)

Time and Cost of Hospitalisation for Salvage Therapy in Adults with Philadelphia Chromosome-Negative B Cell Precursor Relapsed or Refractory Acute Lymphoblastic Leukaemia in Spain
por: Boluda, Blanca, et al.
Publicado: (2018)

Stromal cell-mediated mitochondrial redox adaptation regulates drug resistance in childhood acute lymphoblastic leukemia
por: Liu, Jizhong, et al.
Publicado: (2015)

Brexucabtagene autoleucel for mantle cell lymphoma, B-cell precursor acute lymphoblastic leukaemia
Publicado: (2023)

Targeting the 5T4 oncofetal glycoprotein with an antibody drug conjugate (A1mcMMAF) improves survival in patient-derived xenograft models of acute lymphoblastic leukemia
por: McGinn, Owen J., et al.
Publicado: (2017)

Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): a prospective, risk stratified, randomised, multicentre, open label, controlled therapeutic trial for newly diagnosed childhood acute lymphoblastic leukaemia in India
por: Das, Nandana, et al.
Publicado: (2022)

Comparative treatment costs of risk‐stratified therapy for childhood acute lymphoblastic leukemia in India
por: Mungle, Tushar, et al.
Publicado: (2022)

Development of Aided Long-Latency Response (ALLR) in Children With Cochlear Implant Within 18 Months of Implantation
por: K.C., Theertha Dinesh, et al.
Publicado: (2021)

Allred Scoring of ER-IHC Stained Whole-Slide Images for Hormone Receptor Status in Breast Carcinoma
por: Ahmad Fauzi, Mohammad Faizal, et al.
Publicado: (2022)

Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions
por: Venn, Nicola C., et al.
Publicado: (2022)

French “real life” experience of clofarabine in children with refractory or relapsed acute lymphoblastic leukaemia
por: Trioche, Pascale, et al.
Publicado: (2012)

Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia
por: Ma, Xiaotu, et al.
Publicado: (2015)

Blinatumomab retreatment after relapse in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia
por: Topp, M S, et al.
Publicado: (2018)

Overexpression of epidermal growth factor receptor as a prognostic factor in colorectal cancer on the basis of the Allred scoring system
por: Rokita, Marta, et al.
Publicado: (2013)

Acute disseminated encephalomyelitis mimicking late CNS relapse of acute lymphoblastic leukaemia: case report
por: Kumar, Ram, et al.
Publicado: (2007)

The shape of cancer relapse: Topological data analysis predicts recurrence in paediatric acute lymphoblastic leukaemia
por: Chulián, Salvador, et al.
Publicado: (2023)

Venetoclax and Bortezomib in Relapsed/Refractory Early T-Cell Precursor Acute Lymphoblastic Leukemia
por: La Starza, Roberta, et al.
Publicado: (2019)

Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study
por: Moorman, Anthony V., et al.
Publicado: (2021)

Acute B lymphoblastic leukaemia-propagating cells are present at high frequency in diverse lymphoblast populations
por: Rehe, Klaus, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6f6q8qbrpi6rk8a7elsa6ot54o